HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Menarini Diagnostics Launches New SARS-CoV-2 Antigen Test That Also Measures Viral Load

By HospiMedica International staff writers
Posted on 22 Sep 2020
Print article
Image: Menarini Diagnostics Launches New SARS-CoV-2 Antigen Test That Also Measures Viral Load (Photo courtesy of A. Menarini Diagnostics)
Image: Menarini Diagnostics Launches New SARS-CoV-2 Antigen Test That Also Measures Viral Load (Photo courtesy of A. Menarini Diagnostics)
A new COVID-19 test from A. Menarini Diagnostics (Florence, Italy) to detect the presence of antigens can not only determine whether a patient is positive for COVID-19, but also provide an indication of the viral load, allowing the most infectious and most at-risk patients to be identified immediately.

These tests are unlike molecular biology tests because, although they also use nasopharyngeal swabs to take the sample, antigen tests do not search for the genetic material of the virus. Instead, they check for the presence of antigens and, therefore, for potential infection by searching for specific viral proteins. They do this through instruments which are easy to transport and use, quicker and cheaper and with equally reliable results. One such instrument is the AFIAS Point-of-Care platform distributed by A. Menarini Diagnostics in Italy and other European countries. This device can be used in decentralized settings not directly connected to the analysis laboratory, such as emergency rooms, airports, or other situations where time or patient convenience matter.

Two models are currently available: AFIAS 1, which can handle one test at a time, and AFIAS 6, which allows six samples to be examined at the same time. Moreover, the same platform can also be used to perform serological antibody tests, detecting the presence and measuring the quantity of IgM and IgG antibodies in a patient's blood sample. Using AFIAS 6, for example, three patients can have both serological antibody and antigen tests done at the same time, getting their results in just 12 minutes.

"It is vitally important to provide reliable tests allowing large-scale screening and the rapid detection of positive cases in order to contain the spread of COVID-19," said Fabio Piazzalunga, Global Head of A. Menarini Diagnostics. "Ultimately, our lives and economies will be increasingly reliant on the availability and efficiency of these diagnostic tools."

Related Links:
A. Menarini Diagnostics

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Compact C-Arm
Arcovis DRF-C S21

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more